Category: psoriasis

According to a recent study, most psoriasis patients view their comorbid obesity as unrelated to their skin condition.

According to a new study, smoking and obesity-related factors such as body mass index and waist and hip circumference, are linked to an increased risk of psoriasis.

A real-world study of psoriasis (PsO) and psoriatic arthritis (PsA) patients with apremilast reported no new adverse events or safety signals with results comparable to previous clinical trials.

A new real-world study showed IL-23 inhibitors to be highly effective for the treatment of chronic plaque psoriasis in both biologic-naïve and biologic-non-naïve patients. 

According to a new study, patients with psoriasis have a 20% greater risk of organ-based comorbidities when compared with the general population.

Patients with psoriasis value skin clearance and symptom control as the most important treatment outcomes, according to a new study.

According to a new study, tildrakizumab treatment for psoriasis showed a significant improvement when used for difficult-to-treat areas such as the scalp, nail, palms and genitals.

According to a new study, patients with psoriasis are at an increased risk of developing alopecia areata. 

According to a new study, psoriasis patients, with and without psoriatic arthritis (PsA), self-report using analgesics more than those without the disease. This may be due to increased joint pain.

A new study has shown that clinical response in psoriasis patients treated with ustekinumab tends to vary by anatomical region, with the lower extremities seeing the least response.